Skip to main content
Clinical Trials/NL-OMON56214
NL-OMON56214
Recruiting
Not Applicable

Evaluation of the additional effect of continuous ultrasound bladder monitoring in urotherapy for children with functional daytime urinary incontinence. The SENS-U trial - The SENS U trial

Radboud Universitair Medisch Centrum0 sites480 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Lower urinary tract symptoms/ functional urinary incontinence
Sponsor
Radboud Universitair Medisch Centrum
Enrollment
480
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age \>\= 6 years and \< 16 years
  • Presenting with functional daytime urinary incontinence according to previous
  • definition ( \>\= one episode a month , \>\= 3 months)
  • Diagnosed with overactive bladder, dysfunctional voiding or underactive
  • bladder with or without recurrent urinary tract infections according ICCS
  • criteria/classification
  • Eligible for urotherapy/ bladder training as the treatment of choice by the
  • No current urinary tract infection (UTI) at the start of the study

Exclusion Criteria

  • History of congenital urogenital anomalies except for successfully treated
  • mild infravesical obstruction (meatal stenosis, mild urethral valves) \< 3
  • months before inclusion
  • History of neurological underlying disease
  • Untreated or treated but persisting functional constipation according to Rome
  • IV criteria at the start of the study \< 6 months before inclusion.
  • Recurrent culture proven UTI (less than 3 months before start of the study or
  • not under control by prophylactic antibiotics)
  • Previous urotherapy/ bladder training within 6 months of start of the study
  • Adipositas preventing accurate measurement by the SENS\-U as defined as a BMI

Outcomes

Primary Outcomes

Not specified

Similar Trials